We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.53B
AUM Growth
+$159M
(+3%)
Cap. Flow
-$12.4M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
20.92%
Holding
797
New
64
Increased
251
Reduced
262
Closed
82
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$42M |
| 2 |
CF Industries
CF
|
+$41.4M |
| 3 |
BEAV
B/E Aerospace Inc
BEAV
|
+$36.2M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$33.3M |
| 5 |
Sunoco
SUN
|
+$29.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$55.7M |
| 2 |
ITC
ITC HOLDINGS CORP
ITC
|
+$38.9M |
| 3 |
AGN
Allergan Inc
AGN
|
+$38.3M |
| 4 |
Accenture
ACN
|
+$37.2M |
| 5 |
Tesla
TSLA
|
+$35.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.43% |
| 2 | Financials | 16.55% |
| 3 | Consumer Discretionary | 12.19% |
| 4 | Industrials | 12.01% |
| 5 | Technology | 10.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
526
FNB Corp
FNB
$6.11B
| $213K | ﹤0.01% |
+16,225
| New | +$207K |
2015 Q1
0 quarters
|
|
|
HZNP
527
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $212K | ﹤0.01% |
8,150
-3,000
| -27% | -$55K |
2013 Q3
6 quarters
|
|
528
iShares MSCI Singapore ETF
EWS
$1.46B
| $211K | ﹤0.01% |
8,258
+388
| +5% | +$9.91K |
2013 Q2
7 quarters
|
|
529
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $211K | ﹤0.01% |
4,320
-182
| -4% | -$8.94K |
2014 Q4
1 quarter
|
|
530
Ford
F
$50B
| $207K | ﹤0.01% |
12,839
+1,794
| +16% | +$28.3K |
2013 Q4
5 quarters
|
|
531
Outfront Media
OUT
$5.35B
| $206K | ﹤0.01% |
+6,981
| New | +$198K |
2015 Q1
0 quarters
|
|
532
Trane Technologies
TT
$101B
| $203K | ﹤0.01% |
+2,975
| New | +$197K |
2015 Q1
0 quarters
|
|
533
Conagra Brands
CAG
$6.83B
| $202K | ﹤0.01% |
7,123
-450
| -6% | -$12.4K |
2014 Q4
1 quarter
|
|
534
Edgewell Personal Care
EPC
$1.29B
| $200K | ﹤0.01% |
+1,956
| New | +$194K |
2015 Q1
0 quarters
|
|
535
SFL Corp
SFL
$1.72B
| $197K | ﹤0.01% |
13,300
| – | – |
2013 Q3
6 quarters
|
|
536
Alcoa
AA
$11.2B
| $187K | ﹤0.01% |
6,034
+1,664
| +38% | +$59.8K |
2013 Q2
7 quarters
|
|
537
Rithm Capital
RITM
$4.84B
| $178K | ﹤0.01% |
+11,874
| New | +$164K |
2015 Q1
0 quarters
|
|
|
TAT
538
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $160K | ﹤0.01% |
30,000
-2,000
| -6% | -$9.65K |
2013 Q2
7 quarters
|
|
539
Wendy's
WEN
$1.27B
| $146K | ﹤0.01% |
13,393
+3,228
| +32% | +$34.5K |
2014 Q3
2 quarters
|
|
540
Acacia Research
ACTG
$407M
| $133K | ﹤0.01% |
12,440
| – | – |
2013 Q2
7 quarters
|
|
541
iShares Gold Trust
IAU
$61.6B
| $120K | ﹤0.01% |
+5,219
| New | +$123K |
2015 Q1
0 quarters
|
|
|
FTR
542
DELISTED
Frontier Communications Corp.
FTR
| $105K | ﹤0.01% |
992
-53
| -5% | -$5.87K |
2014 Q1
4 quarters
|
|
543
SiriusXM
SIRI
$9.12B
| $102K | ﹤0.01% |
2,663
+500
| +23% | +$18.8K |
2013 Q2
7 quarters
|
|
|
PLM
544
DELISTED
PolyMet Mining Corp.
PLM
| $100K | ﹤0.01% |
7,780
+800
| +11% | +$9.05K |
2013 Q2
7 quarters
|
|
|
SVLC
545
DELISTED
SILVERCREST MINES INC ORD SHS (CDA)
SVLC
| $95K | ﹤0.01% |
86,000
| – | – |
2013 Q2
7 quarters
|
|
|
ELI
546
DELISTED
ELITE PHARMACEUTICAL
ELI
| $71K | ﹤0.01% |
290,880
| – | – |
2013 Q2
7 quarters
|
|
547
DELISTED
BLUE EARTH, INC. COMMON STOCK
BBLU
| $66K | ﹤0.01% |
74,000
| – | – |
2014 Q3
2 quarters
|
|
|
EXXI
548
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $55K | ﹤0.01% |
15,246
+4,866
| +47% | +$17K |
2014 Q4
1 quarter
|
|
549
Kamada
KMDA
$448M
| $50K | ﹤0.01% |
11,200
-2,800
| -20% | -$12K |
2014 Q3
2 quarters
|
|
|
GPIC
550
DELISTED
Gaming Partners International Corporation
GPIC
| $39K | ﹤0.01% |
1,111,775
| – | – |
2013 Q2
7 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, Geneva Advisors held 797 positions worth $5.53B, up 3% from $5.37B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q1 2015 filing shows 64 new, 251 increased, 262 reduced and 82 closed positions. Its largest new stake was Ulta Beauty: 303,437 shares worth $45.8M. The largest sale was Johnson & Johnson, an estimated $55.7M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q1 2015 buy was Ulta Beauty: 303,437 shares worth $45.8M.
- Geneva Advisors added most to CF Industries in Q1 2015, an estimated $41.4M increase.
- Geneva Advisors's biggest Q1 2015 reduction was Johnson & Johnson, cutting an estimated $55.7M.
- Geneva Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $38.3M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.53B portfolio in Q1 2015.
- Geneva Advisors opened 64 new positions and closed 82 in Q1 2015.
- Geneva Advisors's portfolio value rose 3% quarter-over-quarter to $5.53B.
Based on Geneva Advisors's 13F filing for Q1 2015, filed 5 May 2015.